Metropolis Healthcare reported its standalone quarterly numbers for December 2023, showing a 1.83% increase in net sales compared to the same period in 2022. However, there was also a decrease of 18.67% in net profit and 11.44% in EBITDA. The EPS has decreased from Rs. 6.41 to Rs. 5.21 and the shares have given a return of 19.68% over the last 6 months